Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic

@article{Muzny2013TrichomonasVI,
  title={Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic},
  author={Christina A. Muzny and Charles A. Rivers and Erika Laine Austin and Jane R. Schwebke},
  journal={Sexually Transmitted Infections},
  year={2013},
  volume={89},
  pages={514 - 518}
}
Objective Trichomoniasis vaginalis is a risk factor for the acquisition and transmission of HIV. The objective of this study was to determine the prevalence of T vaginalis (using culture) among HIV-infected women receiving gynaecological care at an university HIV clinic in Alabama in addition to predictors of infection. Methods Electronic medical record review of women presenting to the clinic for gynaecological care during 2006–2012 was performed. Demographic and sexual history data was… Expand
Trichomonas vaginalis AND HIV INFECTION: RELATION AND PREVALENCE AMONG WOMEN IN SOUTHERN BRAZIL
TLDR
The prevalence rates found, lower than those observed in other studies, may be due to the fact that the women evaluated in the present study are part of a low-risk population as well as the limited sample size of HIV positive women. Expand
Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic
TLDR
Initial uptake of T. vaginalis NAAT testing was modest at this HIV clinic yet identified a high prevalence among women tested, and emphasis on the need for testing in HIV+ women is necessary. Expand
Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women
  • S. Hillier
  • Medicine
  • Sexually Transmitted Infections
  • 2013
TLDR
Trichomoniasis is a prevalent sexually transmitted infection (STI) which is more common than Chlamydia trachomatis or Neisseria gonorrhoeae in most populations of women and is linked with a broad range of reproductive health sequelae including preterm delivery, low birth weight, pelvic inflammatory disease and increased susceptibility to HIV. Expand
Trichomonas vaginalis infection and the diagnostic significance of detection tests among Ghanaian outpatients
TLDR
The sensitivity of wet mount microscopy was low for T. vaginalis screening in Ghana and the JD’s Trichomonas V® test should not be considered as an alternative test, and mandatory PCR assay is recommended for confirmation of negative wet mount results. Expand
Gonorrhoea and chlamydia in persons with HIV: number needed to screen
TLDR
The findings suggest the importance of regular, at least annual NG/CT screening, particularly extragenital, of HIV positive MSM of all ages, and provide some support for age-based cutoffs for women and MSW. Expand
Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women
ABSTRACT Trichomoniasis is the most prevalent curable sexually transmitted disease (STD). It has been associated with preterm birth and the acquisition and transmission of HIV. Recently, nucleic acidExpand
Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis.
TLDR
Implementation of MPCR for STI screening can improve TV detection in populations not normally suspected to be at risk and therefore potentially reduce disease transmission or complications associated with undiagnosed infection. Expand
Trichomoniasis the Underestimated Sexually Transmitted Infection
TLDR
It was evident that Trichomonas Vaginalis can co-exist with other infections among women who use illicit drugs and engage in risky sexual behavior and can serve as an early indicator to prompt healthcare providers to test for the presence of STI co-infection that can be potentially fatal if not diagnosed and treated. Expand
Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals
TLDR
This review focuses on the most common STIs seen among HIV-infected individuals and recommendations for screening and prevention. Expand
Current status and prospects for development of a vaccine against Trichomonas vaginalis infections.
TLDR
Based on data from current vaccination studies in animal models, a human vaccine is achievable to intervene on the substantial incidence of infection and Lack of affordable accurate diagnostic tests globally and metronidazole resistance hinder T. vaginalis control efforts. Expand
...
1
2
...

References

SHOWING 1-10 OF 34 REFERENCES
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
TLDR
T. vaginalis infection is strongly associated with an increased risk for HIV infection in this general population of African women and may have a substantial impact on preventing HIV acquisition among women. Expand
Effect of Trichomoniasis Therapy on Genital HIV Viral Burden Among African Women
TLDR
Screening and treatment of vaginal trichomoniasis decrease genital shedding of HIV among HIV-infected women not taking antiretrovirals in South Africa at 1 month after therapy. Expand
Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic.
TLDR
Assessment of the prevalence and incidence of curable sexually transmitted infections in a cohort of HIV-infected women found trichomoniasis was most common, and interventions to prevent curable STI in HIV- Infected women are warranted in primary care settings. Expand
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
TLDR
Treatment and prevention of T. vaginalis infection could reduce HIV-1 risk in women and may also help to reduce the overall risk of infection in women with HIV. Expand
The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.
TLDR
A significant racial disparity exists; the prevalence among non-Hispanic black women was 10.3 times higher than that amongnon-Hispanic white and Mexican American women, and Optimal prevention and control strategies for T. vaginalis infection should be explored as a means of closing the racial disparity gaps and decreasing adverse health outcomes. Expand
Trichomonas vaginalis Among HIV-Infected Women: Are Immune Status or Protease Inhibitor Use Associated With Subsequent T. vaginalis Positivity?
TLDR
Tv is a common STD among HIV-infected women and does not appear to be associated with immune status or PI use, but Aggressive screening might represent a means of reducing the incidence and prevalence of Tv. Expand
Incidence and Predictors of Reinfection with Trichomonas vaginalis in HIV‐infected Women
TLDR
There is a high rate of reinfection with T vaginalis in HIV‐infected women and further research that includes information on sexual partners should be conducted to better describe the reinfections patterns of trichomoniasis. Expand
Frequent Douching and Clinical Outcomes Among HIV-Infected Women
TLDR
This is the first study performed in women infected with HIV to link a significant dose–response relationship between douching and the clinical outcomes of bacterial vaginosis and presence of a sexually transmitted infection, and to examine the association between douched and genital tract HIV-1 RNA shedding. Expand
Trichomonas vaginalis, HIV, and African-Americans.
TLDR
T. vaginalis is highly prevalent among African-Americans in major urban centers of the United States and is often the most common sexually transmitted infection in black women, which could translate into an important amplifying effect since Trichomonas is so common. Expand
Epidemiology of Trichomonas vaginalis: A Prospective Study in China
  • Z. Zhang
  • Medicine
  • Sexually transmitted diseases
  • 1996
TLDR
This study confirmed the relationship between T. vaginalis and multiple sexual partners and suggests that the risk for T. vaginais also may be related to life‐style risk factors. Expand
...
1
2
3
4
...